| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1775-1784, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
A Karsan, E Yee, GG Poirier, P Zhou, R Craig and JM Harlan
McDonald Research Laboratories, University of British Columbia, Vancouver, Canada.
Intact endothelium acts as a sensor and transducer of signals and also provides a nonthrombogenic surface at the blood-vascular wall interface. Hence, mechanisms that maintain the integrity of the endothelium are of interest in physiological and pathological states. In this study we show that apoptosis induced by growth factor and serum deprivation of endothelial cells occurs at all phases of the cell cycle and can be blocked by fibroblast growth factor-2 (FGF-2) independently of its mitogenic activity. As the Bcl-2 family of proteins plays a prominent role in regulating cell survival, we attempted to identify Bcl-2 homologues expressed in endothelial cells. Here we demonstrate that, in addition to the previously identified A1, four other members of the Bcl-2 family, Bcl-2, Mcl-1, Bcl-X(L), and Bax, are expressed in endothelial cells. Of these family members, only Bcl-2 is induced by FGF-2. Overexpression of Bcl-2, using a retroviral vector, protects endothelial cells from serum and growth factor deprivation. There is no difference in FGF-2-induced proliferation between Bcl-2-overexpressing cells and those transduced with the empty retroviral vector. At early time points Bcl-2 is not up-regulated, but FGF-2 still has a protective effect. However, FGF-2 protects only adherent endothelial cells but not those that are cultured in suspension. The early effect of FGF-2 is dependent on tyrosine phosphorylation but not on activation of the MAP kinase pathway. Thus, FGF-2 inhibits endothelial cell apoptosis by Bcl- 2-dependent and independent mechanisms.
This article has been cited by other articles:
![]() |
S. Kondo, Y. Tang, E. A. Scheef, N. Sheibani, and C. M. Sorenson Attenuation of retinal endothelial cell migration and capillary morphogenesis in the absence of bcl-2 Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1521 - C1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Murakami, A. Elfenbein, and M. Simons Non-canonical fibroblast growth factor signalling in angiogenesis Cardiovasc Res, May 1, 2008; 78(2): 223 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J.M. de Jonge, A. C. Weidenaar, A. ter Elst, H. M. Boezen, F. J.G. Scherpen, J. C.A. Bouma-ter Steege, G. J.L. Kaspers, B. F. Goemans, U. Creutzig, M. Zimmermann, et al. Endogenous Vascular Endothelial Growth Factor-C Expression Is Associated with Decreased Drug Responsiveness in Childhood Acute Myeloid Leukemia Clin. Cancer Res., February 1, 2008; 14(3): 924 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lu, W. Jiang, J.-H. Yang, P.-Y. Chang, J. P. Walterscheid, H.-H. Chen, M. Marcelli, D. Tang, Y.-T. Lee, W. S.L. Liao, et al. Electronegative LDL Impairs Vascular Endothelial Cell Integrity in Diabetes by Disrupting Fibroblast Growth Factor 2 (FGF2) Autoregulation Diabetes, January 1, 2008; 57(1): 158 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zhande and A. Karsan Erythropoietin promotes survival of primary human endothelial cells through PI3K-dependent, NF-{kappa}B-independent upregulation of Bcl-xL Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2467 - H2474. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Alavi, L. Acevedo, W. Min, and D. A. Cheresh Chemoresistance of Endothelial Cells Induced by Basic Fibroblast Growth Factor Depends on Raf-1-Mediated Inhibition of the Proapoptotic Kinase, ASK1 Cancer Res., March 15, 2007; 67(6): 2766 - 2772. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ferrari, G. Pintucci, G. Seghezzi, K. Hyman, A. C. Galloway, and P. Mignatti VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis PNAS, November 14, 2006; 103(46): 17260 - 17265. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Limaye, X. Li, C. Hahn, P. Xia, M. C. Berndt, M. A. Vadas, and J. R. Gamble Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members Blood, April 15, 2005; 105(8): 3169 - 3177. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Noseda, L. Chang, G. McLean, J. E. Grim, B. E. Clurman, L. L. Smith, and A. Karsan Notch Activation Induces Endothelial Cell Cycle Arrest and Participates in Contact Inhibition: Role of p21Cip1 Repression Mol. Cell. Biol., October 15, 2004; 24(20): 8813 - 8822. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Pritzker, M. Scatena, and C. M. Giachelli The Role of Osteoprotegerin and Tumor Necrosis Factor-related Apoptosis-inducing Ligand in Human Microvascular Endothelial Cell Survival Mol. Biol. Cell, June 1, 2004; 15(6): 2834 - 2841. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Noseda, G. McLean, K. Niessen, L. Chang, I. Pollet, R. Montpetit, R. Shahidi, K. Dorovini-Zis, L. Li, B. Beckstead, et al. Notch Activation Results in Phenotypic and Functional Changes Consistent With Endothelial-to-Mesenchymal Transformation Circ. Res., April 16, 2004; 94(7): 910 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. MacKenzie, P. Duriez, F. Wong, M. Noseda, and A. Karsan Notch4 Inhibits Endothelial Apoptosis via RBP-J{kappa}-dependent and -independent Pathways J. Biol. Chem., March 19, 2004; 279(12): 11657 - 11663. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Burleigh, K. Stewart, K. M. Grindle, H. H. Kay, and T. G. Golos Influence of Maternal Diabetes on Placental Fibroblast Growth Factor-2 Expression, Proliferation, and Apoptosis Reproductive Sciences, January 1, 2004; 11(1): 36 - 41. [Abstract] [PDF] |
||||
![]() |
C.-H. Chen, T. Jiang, J.-H. Yang, W. Jiang, J. Lu, G. K. Marathe, H. J. Pownall, C. M. Ballantyne, T. M. McIntyre, P. D. Henry, et al. Low-Density Lipoprotein in Hypercholesterolemic Human Plasma Induces Vascular Endothelial Cell Apoptosis by Inhibiting Fibroblast Growth Factor 2 Transcription Circulation, April 29, 2003; 107(16): 2102 - 2108. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Donohue, C. M. Richards, S. A.N. Brown, H. N. Hanscom, J. Buschman, S. Thangada, T. Hla, M. S. Williams, and J. A. Winkles TWEAK Is an Endothelial Cell Growth and Chemotactic Factor That Also Potentiates FGF-2 and VEGF-A Mitogenic Activity Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 594 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Miller, C. J. Sweeney, and G. W. Sledge The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era Ann. Onc., January 1, 2003; 14(1): 20 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsutsumi, V. Hogan, I. R. Nabi, and A. Raz Overexpression of the Autocrine Motility Factor/Phosphoglucose Isomerase Induces Transformation and Survival of NIH-3T3 Fibroblasts Cancer Res., January 1, 2003; 63(1): 242 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Patel, A. Logan, J. C. Watkinson, S. Uz-Zaman, M. C. Sheppard, J. D. Ramsden, and M. C. Eggo Isolation and characterization of human thyroid endothelial cells Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E168 - E176. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Detillieux, F. Sheikh, E. Kardami, and P. A. Cattini Biological activities of fibroblast growth factor-2 in the adult myocardium Cardiovasc Res, January 1, 2003; 57(1): 8 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Hartley, R. A. L. Bayne, L. L. L. Robinson, N. Fulton, and R. A. Anderson Developmental Changes in Expression of Myeloid Cell Leukemia-1 in Human Germ Cells during Oogenesis and Early Folliculogenesis J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3417 - 3427. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Sullivan and J. B. Hoying Flow-Dependent Remodeling in the Carotid Artery of Fibroblast Growth Factor-2 Knockout Mice Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1100 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Chavakis and S. Dimmeler Regulation of Endothelial Cell Survival and Apoptosis During Angiogenesis Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 887 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Munshi, A. Z. Fernandis, R. P. Cherla, I.-W. Park, and R. K. Ganju Lipopolysaccharide-Induced Apoptosis of Endothelial Cells and Its Inhibition by Vascular Endothelial Growth Factor J. Immunol., June 1, 2002; 168(11): 5860 - 5866. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tran, Z. Master, J. L. Yu, J. Rak, D. J. Dumont, and R. S. Kerbel A role for survivin in chemoresistance of endothelial cells mediated by VEGF PNAS, April 2, 2002; 99(7): 4349 - 4354. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. SATO, K. TERUYAMA, T. NAKANO, N. ODA, M. ABE, K. TANAKA, and C. IWASAKA-YAGI Role of Transcription Factors in Angiogenesis: Ets-1 Promotes Angiogenesis As Well As Endothelial Apoptosis Ann. N.Y. Acad. Sci., December 1, 2001; 947(1): 117 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, S. Song, F. Yang, J. L.-S. Au, and M. G. Wientjes Nontoxic Doses of Suramin Enhance Activity of Doxorubicin in Prostate Tumors J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 426 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-L. Guo, S. Wang, and R. W. Colman Kininostatin, an Angiogenic Inhibitor, Inhibits Proliferation and Induces Apoptosis of Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1427 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamamoto, R. Morishita, S.-i. Hayashi, H. Matsushita, H. Nakagami, A. Moriguchi, K. Matsumoto, T. Nakamura, Y. Kaneda, and T. Ogihara Contribution of Bcl-2, but Not Bcl-xL and Bax, to Antiapoptotic Actions of Hepatocyte Growth Factor in Hypoxia-Conditioned Human Endothelial Cells Hypertension, May 1, 2001; 37(5): 1341 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Sweeney, K. D. Miller, S. E. Sissons, S. Nozaki, D. K. Heilman, J. Shen, and G. W. Sledge Jr. The Antiangiogenic Property of Docetaxel Is Synergistic with a Recombinant Humanized Monoclonal Antibody against Vascular Endothelial Growth Factor or 2-Methoxyestradiol but Antagonized by Endothelial Growth Factors Cancer Res., April 1, 2001; 61(8): 3369 - 3372. [Abstract] [Full Text] |
||||
![]() |
K. D. Miller, C. J. Sweeney, and G. W. Sledge Jr Redefining the Target: Chemotherapeutics as Antiangiogenics J. Clin. Oncol., February 15, 2001; 19(4): 1195 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. K. MESSMER, V. A. BRINER, and J. PFEILSCHIFTER Basic Fibroblast Growth Factor Selectively Enhances TNF-{alpha}--Induced Apoptotic Cell Death in Glomerular Endothelial Cells: Effects on Apoptotic Signaling Pathways J. Am. Soc. Nephrol., December 1, 2000; 11(12): 2199 - 2211. [Abstract] [Full Text] |
||||
![]() |
C. K. Ullrich, J. E. Groopman, and R. K. Ganju HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases Blood, August 15, 2000; 96(4): 1438 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sata, M. Kakoki, D. Nagata, H. Nishimatsu, E. Suzuki, T. Aoyagi, S. Sugiura, H. Kojima, T. Nagano, K. Kangawa, et al. Adrenomedullin and Nitric Oxide Inhibit Human Endothelial Cell Apoptosis via a Cyclic GMP-Independent Mechanism Hypertension, July 1, 2000; 36(1): 83 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hughes, M. Nangaku, C. E. Alpers, S. J. Shankland, W. G. Couser, and R. J. Johnson C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis Am J Physiol Renal Physiol, May 1, 2000; 278(5): F747 - F757. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. T. P. Bakker, E. T. van der Meulen, J. A. E. Spaan, and E. VanBavel Organoid culture of cannulated rat resistance arteries: effect of serum factors on vasoactivity and remodeling Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1233 - H1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. O’Connor, J. S. Schechner, C. Adida, M. Mesri, A. L. Rothermel, F. Li, A. K. Nath, J. S. Pober, and D. C. Altieri Control of Apoptosis during Angiogenesis by Survivin Expression in Endothelial Cells Am. J. Pathol., February 1, 2000; 156(2): 393 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Hartnett, C. M. Garcia, and P. A. D’Amore Release of bFGF, an Endothelial Cell Survival Factor, by Osmotic Shock Invest. Ophthalmol. Vis. Sci., November 1, 1999; 40(12): 2945 - 2951. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Rosmorduc, D. Wendum, C. Corpechot, B. Galy, N. Sebbagh, J. Raleigh, C. Housset, and R. Poupon Hepatocellular Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Angiogenesis in Experimental Biliary Cirrhosis Am. J. Pathol., October 1, 1999; 155(4): 1065 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Schwartz, A. Karsan, T. Bombeli, and J. M. Harlan A Novel {beta}1 Integrin-Dependent Mechanism of Leukocyte Adherence to Apoptotic Cells J. Immunol., April 15, 1999; 162(8): 4842 - 4848. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stempien-Otero, A. Karsan, C. J. Cornejo, H. Xiang, T. Eunson, R. S. Morrison, M. Kay, R. Winn, and J. Harlan Mechanisms of Hypoxia-induced Endothelial Cell Death. ROLE OF p53 IN APOPTOSIS J. Biol. Chem., March 19, 1999; 274(12): 8039 - 8045. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Noble, R. G. Wickremasinghe, C. DeCornet, P. Panayiotidis, and K. L. Yong Monocytes Stimulate Expression of the Bcl-2 Family Member, A1, in Endothelial Cells and Confer Protection Against Apoptosis J. Immunol., February 1, 1999; 162(3): 1376 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Korff and H. G. Augustin Integration of Endothelial Cells in Multicellular Spheroids Prevents Apoptosis and Induces Differentiation J. Cell Biol., November 30, 1998; 143(5): 1341 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hu, E. Yee, J. M. Harlan, F. Wong, and A. Karsan Lipopolysaccharide Induces the Antiapoptotic Molecules, A1 and A20, in Microvascular Endothelial Cells Blood, October 15, 1998; 92(8): 2759 - 2765. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-B. Choi, F. Wong, J. M. Harlan, P. M. Chaudhary, L. Hood, and A. Karsan Lipopolysaccharide Mediates Endothelial Apoptosis by a FADD-dependent Pathway J. Biol. Chem., August 7, 1998; 273(32): 20185 - 20188. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Bannerman, J. C. Tupper, W. A. Ricketts, C. F. Bennett, R. K. Winn, and J. M. Harlan A Constitutive Cytoprotective Pathway Protects Endothelial Cells from Lipopolysaccharide-induced Apoptosis J. Biol. Chem., April 27, 2001; 276(18): 14924 - 14932. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Duriez, F. Wong, K. Dorovini-Zis, R. Shahidi, and A. Karsan A1 Functions at the Mitochondria to Delay Endothelial Apoptosis in Response to Tumor Necrosis Factor J. Biol. Chem., June 9, 2000; 275(24): 18099 - 18107. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tran, Z. Master, J. L. Yu, J. Rak, D. J. Dumont, and R. S. Kerbel A role for survivin in chemoresistance of endothelial cells mediated by VEGF PNAS, April 2, 2002; 99(7): 4349 - 4354. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |